1、Q1 2026 Financial&Operational Highlights|April22,2026 1Q1 2026 HighlightsApril22,2026Q1 2026 Financial&Operational Highlights|April22,2026 2Forward-Looking Statements and Use of DocumentForward-looking statements:This presentation contains forward-looking statements within the meaning of Section 27A
2、 of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.Forward-looking statements may be identified by words like anticipate,expect,project,believe,plan,estimate,may,intend and similar words.These forward-looking statements are based on our beliefs,assumptions and esti
3、mates using information available to us at the time and are not intended to be guarantees of future events or performance.These forward-looking statements include,among other things,statements regarding our expected net sales;reported,operational and organic revenue growth rates;adjusted EPS for the
4、 second quarter and full year 2026;free cash flow(FCF);adjusted expenses;tax rates;our financial performance;acquisitions;clinical trials;our business plans and product performance;and new and anticipated product approvals and launches.If our underlying assumptions turn out to be incorrect,or if cer
5、tain risks or uncertainties materialize,actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.These factors,in some cases,have affected and in the future(together with other factors)could affect our ability to implement our
6、business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this presentation.As a result,readers are cautioned not to place undue reliance on any of our forward-looking statements.Factors that may cause such differences can be found in